Last reviewed · How we verify
NCT03856138
Effect of Gut Microbiota and Fecal Inflammatory Marker on Childhood Gastroenteritis
trial in Clinical Infection in 118 participants. Completed in 28 February 2018.
28 February 2018
Quick facts
| Lead sponsor | Chang Gung Memorial Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 118 |
| Start date | 1 December 2015 |
| Primary completion | 28 February 2018 |
| Estimated completion | 28 February 2018 |
| Sites | 1 location across Taiwan |
Conditions studied
- Clinical Infection — all drugs for Clinical Infection →
- Microbial Colonization — all drugs for Microbial Colonization →
- Gastroenteritis — all drugs for Gastroenteritis →
- Inflammatory Response — all drugs for Inflammatory Response →
Sponsor
Chang Gung Memorial Hospital
Who can join
Adults 6 Months to 12, any sex, with Clinical Infection or Microbial Colonization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Childhood gastroenteritis establishes gastrointestinal disease and increase the economic burden, and the pediatric population is especially vulnerable to these gastrointestinal infections. The aim of this study is to evaluate the role of intestinal microbiota and their relationship with childhood gastroenteritis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Probiotic <i>Lactobacillus casei</i>: Effective for Managing Childhood Diarrhea by Altering Gut Microbiota and Attenuating Fecal Inflammatory Markers.
Lai HH, Chiu CH, Kong MS, Chang CJ, et al · · 2019 · cited 83× · PMID 31126062 · DOI 10.3390/nu11051150
Verify or expand the search:
- PubMed search for NCT03856138
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Chang Gung Memorial Hospital trials
Trials by the same sponsor.
- NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
- NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
- NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
- NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
- NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03856138 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
- Last refreshed: 27 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03856138.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing